IE912823A1 - New use of a monoclonal antibody - Google Patents

New use of a monoclonal antibody

Info

Publication number
IE912823A1
IE912823A1 IE282391A IE282391A IE912823A1 IE 912823 A1 IE912823 A1 IE 912823A1 IE 282391 A IE282391 A IE 282391A IE 282391 A IE282391 A IE 282391A IE 912823 A1 IE912823 A1 IE 912823A1
Authority
IE
Ireland
Prior art keywords
monoclonal antibody
cells
infected
antibody
fragment
Prior art date
Application number
IE282391A
Other languages
English (en)
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of IE912823A1 publication Critical patent/IE912823A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C07K16/114—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IE282391A 1990-08-11 1991-08-09 New use of a monoclonal antibody IE912823A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4025499A DE4025499A1 (de) 1990-08-11 1990-08-11 Verwendung der antikoerper br55-2, deren derivate, konjugate und fragmente zur bekaempfung von hiv-infektionen

Publications (1)

Publication Number Publication Date
IE912823A1 true IE912823A1 (en) 1992-02-12

Family

ID=6412074

Family Applications (1)

Application Number Title Priority Date Filing Date
IE282391A IE912823A1 (en) 1990-08-11 1991-08-09 New use of a monoclonal antibody

Country Status (13)

Country Link
EP (1) EP0547079B1 (enExample)
JP (1) JPH06500771A (enExample)
KR (1) KR930701193A (enExample)
AT (1) ATE136469T1 (enExample)
AU (1) AU657489B2 (enExample)
CA (1) CA2088370C (enExample)
DE (2) DE4025499A1 (enExample)
HU (1) HUT64238A (enExample)
IE (1) IE912823A1 (enExample)
PT (1) PT98622A (enExample)
TW (1) TW223019B (enExample)
WO (1) WO1992003165A1 (enExample)
ZA (1) ZA916313B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69230545T2 (de) * 1991-08-21 2000-07-06 Novartis Ag, Basel Antikörperderivate
DE69324584T2 (de) * 1992-05-22 1999-09-23 Novartis Ag, Basel Antiidiotypische monoklonale antikörper gegen den lewis y-spezifischen monoklonalen antikörper br55-2 und deren verwendungen
AU5503899A (en) * 1998-06-29 2000-01-17 Wolfgang Bergter Antiviral and antiretroviral radioimmunomedicaments based on alpha-emitters and beta-emitters

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU592142B2 (en) * 1985-11-25 1990-01-04 Cytogen Corporation Modified viral glycoproteins, diagnostic and therapeutic uses therefore
JPH083487B2 (ja) * 1987-07-31 1996-01-17 株式会社日本抗体研究所 異常応答リンパ球の検出方法並びにこれに用いる検出用試薬及びキット

Also Published As

Publication number Publication date
AU657489B2 (en) 1995-03-16
CA2088370C (en) 2003-03-25
WO1992003165A1 (en) 1992-03-05
ATE136469T1 (de) 1996-04-15
HU9300349D0 (en) 1993-05-28
TW223019B (enExample) 1994-05-01
CA2088370A1 (en) 1992-02-12
PT98622A (pt) 1992-06-30
DE69118702D1 (de) 1996-05-15
ZA916313B (en) 1993-04-28
EP0547079B1 (en) 1996-04-10
KR930701193A (ko) 1993-06-11
DE69118702T2 (de) 1996-09-05
AU8393291A (en) 1992-03-17
EP0547079A1 (en) 1993-06-23
HUT64238A (en) 1993-12-28
JPH06500771A (ja) 1994-01-27
DE4025499A1 (de) 1992-02-13

Similar Documents

Publication Publication Date Title
CA1319899C (en) Monoclonal antibodies to fc receptors for immunoglobulin g on human mononuclear phagocytes
US6096311A (en) Methods for use of monoclonal antibodies specific for the high affinity Fc receptor for immunoglobulin G
JP2942356B2 (ja) 毒素および薬剤を含む治療用複合体
EP0515571B1 (en) Hybrid reagents capable of selectively releasing molecules into cells
CA2172630C (en) Cellular and serum protein anchors and conjugates
ES2352180T3 (es) Anticuerpo monoclonal de anti-tenascina humana.
CA2090317A1 (en) Homoconjugated immunoglobulins
EP0496818B1 (en) MONOCLONAL ANTIBODY SPECIFIC FOR IgA RECEPTOR
CA2006353A1 (en) Monoclonal antibody to human carcinomas
Derocq et al. Comparison of the cytotoxic potency of T101 Fab, F (ab') 2 and whole IgG immunotoxins.
AU657489B2 (en) Monoclonal antibody treats HIV-AIDS
JPH05506142A (ja) Ｈｉｖ蛋白質の非免疫支配エピトープに特異的なモノクローナル抗体
US5523085A (en) Monoclonal antibody in destruction of small cell lung carcinoma
AU627468B2 (en) Antibody modified with toxin
JPS63294795A (ja) ヒト免疫不全ウイルス（ｈｉｖ）の検出と治療のための方法および物質
EP0827513B1 (en) Reagents for treatment and diagnostic visualisation, particularly in cancer
CA1340898C (en) Monoclonal antibodies against lymphoma-associated antigens, hybrid cell lines producing these antibodies, and use therefore
IE921810A1 (en) Me20: monoclonal antibodies and antigen for human melanoma
IL101475A (en) Monoclonal antibodies that respond with F receptors as the binding is not blocked by human GJI
HK1100848B (en) Anti-human tenascin monoclonal antibody
CA2622018A1 (en) Cellular and serum protein anchors and conjugates
HK1100848A1 (en) Anti-human tenascin monoclonal antibody